| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |